http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013122504-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ef4715afa580a995a774f480f2a87ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3fb776d723ba0c01df12677578fa236 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac5a0acf34971241ecd2e64615594b7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3bc4e44fec90e73c99e84196b45d1c6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2011-12-12^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_553ed7383e1a82590c3b6df354befd3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9509681b4309eae95c77f4cf382e99f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7f1cf407193e5abeff268e4c1514e21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8b716811c8e3d91fdb116b6e5bf979d |
| publicationDate | 2013-05-16^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2013122504-A1 |
| titleOfInvention | Expression Levels of COL4A3BP and other Markers Correlating with Progression or Non-Progression of Bladder Cancer |
| abstract | Disclosed is determining expression levels of protective or harmful markers for bladder cancer prognosis; particularly, determining the expression level of COL4A3BP alone or in combination with expression levels of MBNL2, FABP4, and NEK1 or other markers where increased expression levels of these protective markers relative to a control correlates with lack of bladder cancer progression and decreased expression levels correlate with bladder cancer progression or death. Also disclosed particularly is determining the expression level of COL4A1 alone or in combination with expression levels of UBE2C, BIRC5, COL18A1, KPNA2, MSN, ACTA2, and CDC25B or other markers where increased expression levels of these harmful markers relative to a control correlates with bladder cancer progression or death and decreased expression levels correlate with lack of bladder cancer progression. Also disclosed are signatures of protective and harmful markers to predict likelihood of bladder cancer progression or non-progression. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9165115-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014214870-A1 |
| priorityDate | 2011-11-14^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 288 of 288.